DK2544657T3 - Anvendelse af amisulprid til behandling af post-operativ kvalme og opkastning - Google Patents

Anvendelse af amisulprid til behandling af post-operativ kvalme og opkastning

Info

Publication number: DK2544657T3
Authority: DK; Denmark
Prior art keywords: amisulpride; vomiting; treat post; operative nausea; nausea
Prior art date: 2010-03-11

Application number

DK11709793.1T

Other languages

English (en)

Inventor

Julian Clive Gilbert

Robert William Gristwood

Nicola Cooper

Gabriel Fox

Original Assignee

Acacia Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-03-11

Filing date

2011-03-10

Publication date

2014-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42136792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2544657(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-03-10 Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd

2014-08-11 Application granted granted Critical

2014-08-11 Publication of DK2544657T3 publication Critical patent/DK2544657T3/da

Links

208000031649 Postoperative Nausea and Vomiting Diseases 0.000 title 1
NTJOBXMMWNYJFB-UHFFFAOYSA-N amisulpride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=C(N)C=C1OC NTJOBXMMWNYJFB-UHFFFAOYSA-N 0.000 title 1
229960003036 amisulpride Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Hospice & Palliative Care (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK11709793.1T 2010-03-11 2011-03-10 Anvendelse af amisulprid til behandling af post-operativ kvalme og opkastning DK2544657T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1004020.2A GB201004020D0 (en)	2010-03-11	2010-03-11	New therapeutic use
PCT/GB2011/050472 WO2011110854A2 (en)	2010-03-11	2011-03-10	The use of amisulpride as an anti-emetic

Publications (1)

Publication Number	Publication Date
DK2544657T3 true DK2544657T3 (da)	2014-08-11

Family

ID=42136792

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK14173186.9T DK2796171T3 (da)	2010-03-11	2011-03-10	Anvendelse af amisulprid til behandling af opiat-induceret kvalme og opkastning
DK11709793.1T DK2544657T3 (da)	2010-03-11	2011-03-10	Anvendelse af amisulprid til behandling af post-operativ kvalme og opkastning
DK12188047.0T DK2567690T3 (da)	2010-03-11	2011-03-10	Anvendelse af amisulphrid til behandling af kemoterapi-induceret kvalme og opkast

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK14173186.9T DK2796171T3 (da)	2010-03-11	2011-03-10	Anvendelse af amisulprid til behandling af opiat-induceret kvalme og opkastning

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK12188047.0T DK2567690T3 (da)	2010-03-11	2011-03-10	Anvendelse af amisulphrid til behandling af kemoterapi-induceret kvalme og opkast

Country Status (26)

Country	Link
US (12)	US9084765B2 (da)
EP (3)	EP2796171B1 (da)
JP (2)	JP5886213B2 (da)
KR (1)	KR101738201B1 (da)
CN (1)	CN102892407B (da)
AU (1)	AU2011225898B2 (da)
BR (1)	BR112012022746B1 (da)
CA (1)	CA2792392C (da)
CY (3)	CY1115487T1 (da)
DK (3)	DK2796171T3 (da)
EA (1)	EA030335B1 (da)
ES (3)	ES2665418T3 (da)
GB (1)	GB201004020D0 (da)
HR (3)	HRP20140744T1 (da)
HU (1)	HUE037088T2 (da)
IL (1)	IL221746A (da)
LT (1)	LT2796171T (da)
MX (3)	MX388787B (da)
NO (1)	NO2796171T3 (da)
NZ (1)	NZ602279A (da)
PL (3)	PL2796171T3 (da)
PT (3)	PT2796171T (da)
RS (3)	RS53466B (da)
SI (3)	SI2544657T1 (da)
SM (3)	SMT201800188T1 (da)
WO (1)	WO2011110854A2 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201004020D0 (en)	2010-03-11	2010-04-21	Acacia Pharma Ltd	New therapeutic use
CN104435861A (zh) *	2014-12-22	2015-03-25	济南伟传信息技术有限公司	一种治疗妊娠剧吐的茶
GB201506116D0 (en) *	2015-04-10	2015-05-27	Acacia Pharma Ltd	Kit and combination therapy for nausea and vomiting
JP2018530744A (ja)	2015-09-02	2018-10-18	カリフォルニアインスティチュートオブテクノロジー	低濃度の硫化水素ガスの分光学的検出のための方法および装置
GB201618425D0 (en) *	2016-11-01	2016-12-14	Acacia Pharma Ltd	method
GB201702250D0 (en) *	2017-02-10	2017-03-29	Acacia Pharma Ltd	Method
WO2019113084A1 (en)	2017-12-05	2019-06-13	Sunovion Pharmaceuticals Inc.	Crystal forms and production methods thereof
CN118593482A (zh)	2017-12-05	2024-09-06	赛诺维信制药公司	非外消旋混合物及其用途
US20220323409A1 (en) *	2019-06-04	2022-10-13	Sunovion Pharmaceuticals Inc.	Modified release formulations and uses thereof
MX2021014774A (es)	2019-06-04	2022-02-03	Sunovion Pharmaceuticals Inc	Formulaciones de liberacion modificada y usos de las mismas.
CA3148042A1 (en) *	2019-07-31	2021-02-04	Astellas Pharma Inc.	Pharmaceutical composition for otic administration
CA3187665A1 (en)	2020-07-06	2022-01-13	Acacia Pharma Ltd	Therapy of post-operative nausea and vomiting
EP4496797A1 (en)	2022-03-21	2025-01-29	Gasherbrum Bio, Inc.	5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
EP4508047A1 (en)	2022-04-14	2025-02-19	Gasherbrum Bio, Inc.	Heterocyclic glp-1 agonists
KR20250157491A (ko)	2022-12-15	2025-11-04	가셔브룸 바이오, 인크.	Glp-1 효능제 활성을 갖는 화합물의 염 및 고체 형태
EP4638440A1 (en)	2022-12-22	2025-10-29	Gasherbrum Bio, Inc.	Heterocyclic glp-1 agonists
CN120693338A (zh)	2022-12-22	2025-09-23	加舒布鲁姆生物公司	杂环的glp-1激动剂
IL322686A (en)	2023-02-16	2025-10-01	Gasherbrum Bio Inc	Heterocyclic glp-1 agonists
CN121773120A (zh)	2023-06-30	2026-03-31	加舒布鲁姆生物公司	杂环glp-1激动剂
AR133241A1 (es)	2023-07-13	2025-09-10	Aconcagua Bio Inc	Compuestos, composiciones y métodos
EP4743174A1 (en)	2023-07-13	2026-05-20	Aconcagua Bio Inc	CALCITONIN AND/OR AMYLIN RECEPTOR ACTIVITY MODULATORS
WO2025045208A1 (en)	2023-08-31	2025-03-06	Gasherbrum Bio, Inc.	Heteroaryl-heterocycloalkyl-based glp-1 agonists
WO2025137307A1 (en)	2023-12-20	2025-06-26	Gasherbrum Bio, Inc.	Heterocyclic glp-1 agonists
WO2025171341A2 (en)	2024-02-08	2025-08-14	Aconcagua Bio, Inc.	Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
WO2025171340A1 (en)	2024-02-08	2025-08-14	Aconcagua Bio, Inc.	The treatment of calcitonin- and/or amylin-receptor associated conditions
WO2025189141A1 (en)	2024-03-08	2025-09-12	Annapurna Bio, Inc.	Methods for treating obesity and increasing weight loss
WO2026041075A1 (en)	2024-08-21	2026-02-26	Gasherbrum Bio, Inc.	Gpl-1 agonists
WO2026051998A1 (en)	2024-09-04	2026-03-12	Aconcagua Bio, Inc.	Compounds, compositions, and methods
WO2026096926A1 (en)	2024-11-01	2026-05-07	Aconcagua Bio, Inc.	Compounds, compositions, and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2415099A1 (fr) *	1978-01-20	1979-08-17	Ile De France	Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
US6169094B1 (en) *	1998-07-14	2001-01-02	Sanofi-Synthelabo	Compositions of (S) (-)-amisulpride
DE10163421A1 (de) *	2001-12-21	2003-07-31	Gruenenthal Gmbh	Verwendung von (+)-(1S,2S)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)phenol als Antiemetikum
DE102005013726A1 (de) *	2005-03-22	2006-09-28	Grünenthal GmbH	Transdermale therapeutische Systeme mit verbesserter Verträglichkeit
GB0506800D0 (en) *	2005-04-04	2005-05-11	Merck Sharp & Dohme	New uses
WO2007067714A2 (en) *	2005-12-08	2007-06-14	The Mclean Hospital Corporation	Treatment of sequelae of psychiatric disorders
NZ570039A (en)	2006-01-27	2011-07-29	Eurand Inc	Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
WO2007096489A1 (fr) *	2006-02-17	2007-08-30	Trimaran Limited	Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions
US7825156B2 (en) *	2007-02-02	2010-11-02	Copharms	Method of treating bipolar depression with a benzamide derivative
JP5714910B2 (ja) *	2008-01-09	2015-05-07	チャールストンラボラトリーズ，インコーポレイテッド	薬学的組成物
US8138169B2 (en) *	2008-04-11	2012-03-20	Comgenrx, Inc.	Combination therapy for bipolar disorder
GB201004020D0 (en)	2010-03-11	2010-04-21	Acacia Pharma Ltd	New therapeutic use

2010
- 2010-03-11 GB GBGB1004020.2A patent/GB201004020D0/en not_active Ceased
2011
- 2011-03-10 NO NO14173186A patent/NO2796171T3/no unknown
- 2011-03-10 JP JP2012556586A patent/JP5886213B2/ja active Active
- 2011-03-10 NZ NZ602279A patent/NZ602279A/en unknown
- 2011-03-10 PL PL14173186T patent/PL2796171T3/pl unknown
- 2011-03-10 MX MX2019015396A patent/MX388787B/es unknown
- 2011-03-10 SI SI201130236T patent/SI2544657T1/sl unknown
- 2011-03-10 LT LTEP14173186.9T patent/LT2796171T/lt unknown
- 2011-03-10 BR BR112012022746-7A patent/BR112012022746B1/pt active IP Right Grant
- 2011-03-10 CN CN201180018552.XA patent/CN102892407B/zh not_active Ceased
- 2011-03-10 EP EP14173186.9A patent/EP2796171B1/en active Active
- 2011-03-10 KR KR1020127024111A patent/KR101738201B1/ko active Active
- 2011-03-10 SI SI201130237T patent/SI2567690T1/sl unknown
- 2011-03-10 DK DK14173186.9T patent/DK2796171T3/da active
- 2011-03-10 PT PT141731869T patent/PT2796171T/pt unknown
- 2011-03-10 PL PL11709793T patent/PL2544657T3/pl unknown
- 2011-03-10 HU HUE14173186A patent/HUE037088T2/hu unknown
- 2011-03-10 PT PT117097931T patent/PT2544657E/pt unknown
- 2011-03-10 ES ES14173186.9T patent/ES2665418T3/es active Active
- 2011-03-10 DK DK11709793.1T patent/DK2544657T3/da active
- 2011-03-10 HR HRP20140744AT patent/HRP20140744T1/hr unknown
- 2011-03-10 AU AU2011225898A patent/AU2011225898B2/en active Active
- 2011-03-10 RS RS20140410A patent/RS53466B/sr unknown
- 2011-03-10 SI SI201131446T patent/SI2796171T1/en unknown
- 2011-03-10 MX MX2012010411A patent/MX2012010411A/es active IP Right Grant
- 2011-03-10 MX MX2015003664A patent/MX370629B/es unknown
- 2011-03-10 CA CA2792392A patent/CA2792392C/en active Active
- 2011-03-10 DK DK12188047.0T patent/DK2567690T3/da active
- 2011-03-10 RS RS20140411A patent/RS53467B/sr unknown
- 2011-03-10 ES ES12188047.0T patent/ES2496099T3/es active Active
- 2011-03-10 EP EP11709793.1A patent/EP2544657B1/en active Active
- 2011-03-10 WO PCT/GB2011/050472 patent/WO2011110854A2/en not_active Ceased
- 2011-03-10 SM SM20180188T patent/SMT201800188T1/it unknown
- 2011-03-10 RS RS20180349A patent/RS57032B1/sr unknown
- 2011-03-10 ES ES11709793.1T patent/ES2496092T3/es active Active
- 2011-03-10 EA EA201290833A patent/EA030335B1/ru unknown
- 2011-03-10 EP EP12188047.0A patent/EP2567690B1/en active Active
- 2011-03-10 PL PL12188047T patent/PL2567690T3/pl unknown
- 2011-03-10 PT PT121880470T patent/PT2567690E/pt unknown
2012
- 2012-07-26 US US13/559,168 patent/US9084765B2/en active Active
- 2012-07-26 US US13/559,253 patent/US8686019B2/en active Active
- 2012-09-02 IL IL221746A patent/IL221746A/en active IP Right Grant
2014
- 2014-02-04 US US14/172,194 patent/US9119836B2/en active Active
- 2014-08-01 HR HRP20140745AT patent/HRP20140745T1/hr unknown
- 2014-08-14 CY CY20141100657T patent/CY1115487T1/el unknown
- 2014-08-14 CY CY20141100656T patent/CY1115485T1/el unknown
- 2014-09-10 SM SM201400127T patent/SMT201400127B/xx unknown
- 2014-09-10 SM SM201400126T patent/SMT201400126B/xx unknown
2015
- 2015-07-29 US US14/812,148 patent/US9545426B2/en active Active
- 2015-09-24 JP JP2015187057A patent/JP6279526B2/ja active Active
2016
- 2016-12-09 US US15/374,174 patent/US9889118B2/en active Active
2017
- 2017-10-23 US US15/790,481 patent/US10085970B2/en active Active
2018
- 2018-03-14 HR HRP20180436TT patent/HRP20180436T1/hr unknown
- 2018-04-18 CY CY20181100416T patent/CY1120170T1/el unknown
- 2018-08-20 US US16/105,268 patent/US10525033B2/en active Active
2019
- 2019-11-27 US US16/697,986 patent/US20200093792A1/en not_active Abandoned
2020
- 2020-09-08 US US17/013,987 patent/US20210228543A1/en not_active Abandoned
2022
- 2022-06-07 US US17/834,000 patent/US20220296570A1/en not_active Abandoned
2023
- 2023-01-11 US US18/095,612 patent/US12194022B2/en active Active
2024
- 2024-12-06 US US18/972,484 patent/US20250186394A1/en active Pending

Also Published As

Publication number	Publication date
ES2665418T3 (es)	2018-04-25
NO2796171T3 (da)	2018-06-30
US20200093792A1 (en)	2020-03-26
US20130022689A1 (en)	2013-01-24
US12194022B2 (en)	2025-01-14
KR20130045241A (ko)	2013-05-03
EP2796171A1 (en)	2014-10-29
EA201290833A1 (ru)	2013-09-30
DK2796171T3 (da)	2018-05-07
JP2013522181A (ja)	2013-06-13
SI2796171T1 (en)	2018-05-31
EP2544657B1 (en)	2014-07-16
CY1120170T1 (el)	2018-12-12
WO2011110854A2 (en)	2011-09-15
US9119836B2 (en)	2015-09-01
US9084765B2 (en)	2015-07-21
PT2567690E (pt)	2014-09-03
US10525033B2 (en)	2020-01-07
PL2567690T3 (pl)	2014-11-28
RS53467B (sr)	2014-12-31
US20180353473A1 (en)	2018-12-13
SMT201400127B (it)	2015-05-05
CY1115487T1 (el)	2017-01-04
EP2567690A1 (en)	2013-03-13
PL2796171T3 (pl)	2018-07-31
WO2011110854A3 (en)	2011-11-10
EA030335B1 (ru)	2018-07-31
PT2796171T (pt)	2018-04-24
US20250186394A1 (en)	2025-06-12
US20180042896A1 (en)	2018-02-15
DK2567690T3 (da)	2014-08-11
US20150335616A1 (en)	2015-11-26
CN102892407A (zh)	2013-01-23
KR101738201B1 (ko)	2017-05-19
MX370629B (es)	2019-12-18
US10085970B2 (en)	2018-10-02
US9545426B2 (en)	2017-01-17
AU2011225898A1 (en)	2012-10-04
SI2567690T1 (sl)	2014-12-31
US20140147517A1 (en)	2014-05-29
US8686019B2 (en)	2014-04-01
HK1179152A1 (zh)	2013-09-27
SMT201800188T1 (it)	2018-07-17
EP2544657A2 (en)	2013-01-16
US20170087128A1 (en)	2017-03-30
HRP20140745T1 (hr)	2014-09-26
CY1115485T1 (el)	2017-01-04
AU2011225898B2 (en)	2014-07-03
US20220296570A1 (en)	2022-09-22
EP2567690B1 (en)	2014-07-16
CN102892407B (zh)	2016-03-23
MX2019015396A (es)	2020-02-07
JP6279526B2 (ja)	2018-02-14
IL221746A (en)	2017-03-30
GB201004020D0 (en)	2010-04-21
BR112012022746B1 (pt)	2021-09-28
HUE037088T2 (hu)	2018-08-28
ES2496092T3 (es)	2014-09-18
PT2544657E (pt)	2014-09-03
RS57032B1 (sr)	2018-05-31
EP2796171B1 (en)	2018-01-31
CA2792392C (en)	2018-06-19
BR112012022746A2 (pt)	2016-07-05
PL2544657T3 (pl)	2014-10-31
US9889118B2 (en)	2018-02-13
JP5886213B2 (ja)	2016-03-16
JP2016028090A (ja)	2016-02-25
MX2012010411A (es)	2012-11-30
US20230144973A1 (en)	2023-05-11
SI2544657T1 (sl)	2014-12-31
ES2496099T3 (es)	2014-09-18
US20210228543A1 (en)	2021-07-29
US20130022688A1 (en)	2013-01-24
NZ602279A (en)	2014-08-29
HRP20140744T1 (hr)	2014-09-26
LT2796171T (lt)	2018-05-10
RS53466B (sr)	2014-12-31
MX388787B (es)	2025-03-20
HRP20180436T1 (hr)	2018-05-04
CA2792392A1 (en)	2011-09-15
SMT201400126B (it)	2015-05-05

Publication	Publication Date	Title
SI2544657T1 (sl)	2014-12-31	Uporaba amisulprida za zdravljenje postoperativne slabosti in bruhanja
DK2579877T3 (da)	2014-10-13	Morpholinopyrimidiner og deres anvendelse til terapi
DK2596235T3 (da)	2014-09-22	Havbølgekraftværk
HRP20181695T1 (hr)	2018-12-14	Kristalni oblik inhibitora benzilbenzena sglt2
HRP20160551T8 (hr)	2016-11-18	Kombinirana terapija s pripravcima nanočestica taksana i hedgehog inhibitora
DK3461847T3 (da)	2020-12-14	Humaniserede antistoffer mod LIV-1 og anvendelse heraf til behandling af cancer
BR112012017118A2 (pt)	2017-06-20	método para produzir filme e filme
IL227193B (en)	2018-03-29	Plant extracts for the treatment and prevention of infections
LT3444512T (lt)	2024-01-10	Vamzdžių konstrukcija
DK2633007T3 (da)	2020-02-17	Produktion af regenererbar biobenzin
DK2658551T3 (da)	2020-09-21	Behandling af erektil dysfunktion og andre indikationer
BR112013011340A2 (pt)	2018-05-02	géis e hidro géis
HRP20160922T1 (hr)	2016-10-07	Oligopeptidni spojevi i njihove uporabe
PL2580240T3 (pl)	2020-03-31	Przeciwciała s100a4 i ich terapeutyczne zastosowania
DK2627673T3 (da)	2017-11-06	Terapier til forbedring af lungefunktionen
DK2353927T3 (da)	2013-03-11	Forankrings-system og indretninger
DK2642992T3 (da)	2021-03-01	Forbindelser og anvendelse deraf
EP3581563C0 (en)	2023-06-28	Ship inhibitors and uses thereof
DK3446565T3 (da)	2024-01-22	Fremgangsmåder til behandling af antipsykotika-induceret vægtøgning
FI20105804A0 (fi)	2010-07-15	Aaltovoimala
DK2369170T3 (da)	2013-08-05	Bølgekraftværk
BR112013012004A2 (pt)	2016-08-30	luminária e módulo
EP2658539A4 (en)	2014-09-24	COMPOSITION FOR PREVENTING EVIL OR CRUSHING
DK2566505T3 (da)	2020-01-20	Fremføring af kolesterylester til steroidogene væv
FI20105250A0 (fi)	2010-03-12	Menetelmä tornimaisten rakenteiden perustusten yhteydessä ja tornimaisten rakenteiden perustus